[
  {
    "ts": null,
    "headline": "Battle of Benefits: Will UNH Deliver the Bigger Dose or CVS? (Revised)",
    "summary": "CVS's rising margins, stronger guidance and sharper valuation edge make it stand out in the UNH vs. CVS upside debate.",
    "url": "https://finnhub.io/api/news?id=25cb3c8a6f2365bfe6112a3000a06e716dcc999fc6096a0a46354b65484fd774",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1764183900,
      "headline": "Battle of Benefits: Will UNH Deliver the Bigger Dose or CVS? (Revised)",
      "id": 137619109,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CVS",
      "source": "Yahoo",
      "summary": "CVS's rising margins, stronger guidance and sharper valuation edge make it stand out in the UNH vs. CVS upside debate.",
      "url": "https://finnhub.io/api/news?id=25cb3c8a6f2365bfe6112a3000a06e716dcc999fc6096a0a46354b65484fd774"
    }
  },
  {
    "ts": null,
    "headline": "Battle of Benefits: Will UNH Deliver the Bigger Dose or CVH?",
    "summary": "CVS's rising margins, stronger guidance and sharper valuation edge make it stand out in the UNH vs. CVS upside debate.",
    "url": "https://finnhub.io/api/news?id=3cdf218e1f2f7badaf1fd331e991eeda181a4cde066e5cd9b561395572f837f1",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1764172680,
      "headline": "Battle of Benefits: Will UNH Deliver the Bigger Dose or CVH?",
      "id": 137614515,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CVS",
      "source": "Yahoo",
      "summary": "CVS's rising margins, stronger guidance and sharper valuation edge make it stand out in the UNH vs. CVS upside debate.",
      "url": "https://finnhub.io/api/news?id=3cdf218e1f2f7badaf1fd331e991eeda181a4cde066e5cd9b561395572f837f1"
    }
  },
  {
    "ts": null,
    "headline": "Building A $100,000 Dividend Portfolio: Maximizing SCHD's Income With November's Top High-Yield Stocks",
    "summary": "This article presents a diversified $100,000 high-yield dividend portfolio for November 2025, blending income, dividend growth, and reduced volatility.",
    "url": "https://finnhub.io/api/news?id=c27cdc4703d413438a3c9bcaee7d662db3d1f54ef7388f325f8030c9c8e5042a",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1764169200,
      "headline": "Building A $100,000 Dividend Portfolio: Maximizing SCHD's Income With November's Top High-Yield Stocks",
      "id": 137615156,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/965085606/image_965085606.jpg?io=getty-c-w1536",
      "related": "CVS",
      "source": "SeekingAlpha",
      "summary": "This article presents a diversified $100,000 high-yield dividend portfolio for November 2025, blending income, dividend growth, and reduced volatility.",
      "url": "https://finnhub.io/api/news?id=c27cdc4703d413438a3c9bcaee7d662db3d1f54ef7388f325f8030c9c8e5042a"
    }
  },
  {
    "ts": null,
    "headline": "These stocks have strong total shareholder returns, says Morgan Stanley",
    "summary": "Morgan Stanley screened for names that have robust returns, including dividends and stock buybacks.",
    "url": "https://finnhub.io/api/news?id=1d05392bd3a2b2325afc061155c9235167f67ae0f466d83773660dbb4f1d0de7",
    "source": "CNBC",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1764156412,
      "headline": "These stocks have strong total shareholder returns, says Morgan Stanley",
      "id": 137613723,
      "image": "https://image.cnbcfm.com/api/v1/image/108096950-17386717192025-02-04t114812z_1411697178_rc22x9avi1pz_rtrmadp_0_marathon-ptrlum-results.jpeg?v=1745860282&w=1920&h=1080",
      "related": "CVS",
      "source": "CNBC",
      "summary": "Morgan Stanley screened for names that have robust returns, including dividends and stock buybacks. ",
      "url": "https://finnhub.io/api/news?id=1d05392bd3a2b2325afc061155c9235167f67ae0f466d83773660dbb4f1d0de7"
    }
  },
  {
    "ts": null,
    "headline": "How Recent Developments Are Shaping the CVS Health Investment Story",
    "summary": "CVS Health stock has seen its consensus analyst price target edge down slightly from $91.52 to $91.48, a reflection of tempered optimism following recent earnings. Analysts cite a mix of upbeat and cautious factors shaping their outlooks; the modest adjustment captures both lingering industry challenges and growing confidence in the company’s execution. Stay tuned to learn how you can keep informed on further shifts in analyst sentiment as the narrative for CVS Health continues to...",
    "url": "https://finnhub.io/api/news?id=4d1132baf572436c24700e13244602c8b43defca651bbde2ac70230551f00507",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1764145061,
      "headline": "How Recent Developments Are Shaping the CVS Health Investment Story",
      "id": 137611499,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CVS",
      "source": "Yahoo",
      "summary": "CVS Health stock has seen its consensus analyst price target edge down slightly from $91.52 to $91.48, a reflection of tempered optimism following recent earnings. Analysts cite a mix of upbeat and cautious factors shaping their outlooks; the modest adjustment captures both lingering industry challenges and growing confidence in the company’s execution. Stay tuned to learn how you can keep informed on further shifts in analyst sentiment as the narrative for CVS Health continues to...",
      "url": "https://finnhub.io/api/news?id=4d1132baf572436c24700e13244602c8b43defca651bbde2ac70230551f00507"
    }
  }
]